Shopping Cart
- Remove All
Your shopping cart is currently empty
PARP/EZH2-IN-1 is a novel dual inhibitor targeting PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for treating triple-negative breast cancer with wild-type BRCA.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 mg | $970 | Backorder |
| Description | PARP/EZH2-IN-1 is a novel dual inhibitor targeting PARP (IC50 6.87 nM) and EZH2 (IC50 36.51 nM), showing promising potential for treating triple-negative breast cancer with wild-type BRCA. |
| Targets&IC50 | PARP1:6.87 nM (IC50), EZH2:36.51 nM (IC50) |
| Synonyms | PARP/EZH2-IN-1 |
| Molecular Weight | 768.85 |
| Formula | C43H41FN8O5 |
| Cas No. | 2687273-52-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.